Harnessing the anti-cancer natural product nimbolide for targeted protein degradation JN Spradlin, X Hu, CC Ward, SM Brittain, MD Jones, L Ou, M To, ... Nature chemical biology 15 (7), 747-755, 2019 | 356 | 2019 |
Magnitude of therapeutic STING activation determines CD8+ T cell-mediated anti-tumor immunity KE Sivick, AL Desbien, LH Glickman, GL Reiner, L Corrales, NH Surh, ... Cell reports 25 (11), 3074-3085. e5, 2018 | 354 | 2018 |
Covalent ligand screening uncovers a RNF4 E3 ligase recruiter for targeted protein degradation applications CC Ward, JI Kleinman, SM Brittain, PS Lee, CYS Chung, K Kim, Y Petri, ... ACS chemical biology 14 (11), 2430-2440, 2019 | 268 | 2019 |
The most common functional groups in bioactive molecules and how their popularity has evolved over time P Ertl, E Altmann, JM McKenna Journal of medicinal chemistry 63 (15), 8408-8418, 2020 | 245 | 2020 |
Deubiquitinase-targeting chimeras for targeted protein stabilization NJ Henning, L Boike, JN Spradlin, CC Ward, G Liu, E Zhang, BP Belcher, ... Nature chemical biology 18 (4), 412-421, 2022 | 201 | 2022 |
Asymmetric palladium-catalyzed directed intermolecular fluoroarylation of styrenes EPA Talbot, TA Fernandes, JM McKenna, FD Toste Journal of the American Chemical Society 136 (11), 4101-4104, 2014 | 153 | 2014 |
Discovery of a covalent FEM1B recruiter for targeted protein degradation applications NJ Henning, AG Manford, JN Spradlin, SM Brittain, E Zhang, JM McKenna, ... Journal of the American Chemical Society 144 (2), 701-708, 2022 | 134 | 2022 |
The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy IM McLay, F Halley, JE Souness, J McKenna, V Benning, M Birrell, ... Bioorganic & medicinal chemistry 9 (2), 537-554, 2001 | 124 | 2001 |
Chemoproteomics-enabled discovery of covalent RNF114-based degraders that mimic natural product function M Luo, JN Spradlin, L Boike, B Tong, SM Brittain, JM McKenna, ... Cell chemical biology 28 (4), 559-566. e15, 2021 | 120 | 2021 |
Bardoxolone conjugation enables targeted protein degradation of BRD4 B Tong, M Luo, Y Xie, JN Spradlin, JA Tallarico, JM McKenna, M Schirle, ... Scientific reports 10 (1), 15543, 2020 | 110 | 2020 |
Discovery of a functional covalent ligand targeting an intrinsically disordered cysteine within MYC L Boike, AG Cioffi, FC Majewski, NJ Henning, MD Jones, G Liu, ... Cell chemical biology 28 (1), 4-13. e17, 2021 | 107 | 2021 |
Manumycin polyketides act as molecular glues between UBR7 and P53 Y Isobe, M Okumura, LM McGregor, SM Brittain, MD Jones, X Liang, ... Nature chemical biology 16 (11), 1189-1198, 2020 | 105 | 2020 |
An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors JM McKenna, F Halley, JE Souness, IM McLay, SD Pickett, AJ Collis, ... Journal of medicinal chemistry 45 (11), 2173-2184, 2002 | 102 | 2002 |
A nimbolide-based kinase degrader preferentially degrades oncogenic BCR-ABL B Tong, JN Spradlin, LFT Novaes, E Zhang, X Hu, M Moeller, SM Brittain, ... ACS chemical biology 15 (7), 1788-1794, 2020 | 90 | 2020 |
The development and mechanistic investigation of a palladium-catalyzed 1, 3-arylfluorination of chromenes RT Thornbury, V Saini, TA Fernandes, CB Santiago, EPA Talbot, ... Chemical Science 8 (4), 2890-2897, 2017 | 84 | 2017 |
Gold‐Catalyzed Redox Synthesis of Imidazo[1,2‐a]pyridines using Pyridine N‐Oxide and Alkynes EPA Talbot, M Richardson, JM McKenna, FD Toste Advanced synthesis & catalysis 356 (4), 687-691, 2014 | 77 | 2014 |
Rational chemical design of molecular glue degraders ES Toriki, JW Papatzimas, K Nishikawa, D Dovala, AO Frank, MJ Hesse, ... ACS central science 9 (5), 915-926, 2023 | 76 | 2023 |
Studies on the stereoselective synthesis of the marine antitumor agent eleutherobin R Carter, K Hodgetts, J McKenna, P Magnus, S Wren Tetrahedron 56 (26), 4367-4382, 2000 | 75 | 2000 |
Heteroaryl compounds, compositions thereof, and methods of treatment therewith DS Mortensen, MMD Mederos, JJ Sapienza, RJ Albers, SS Clareen, ... US Patent 7,968,556, 2011 | 62 | 2011 |
Chemoproteomics-enabled discovery of a covalent molecular glue degrader targeting NF-κB EA King, Y Cho, NS Hsu, D Dovala, JM McKenna, JA Tallarico, M Schirle, ... Cell chemical biology 30 (4), 394-402. e9, 2023 | 52 | 2023 |